The cholinergic hypothesis of geriatric memory dysfunction

RT Bartus, RL Dean III, B Beer, AS Lippa - Science, 1982 - science.org
Biochemical, electrophysiological, and pharmacological evidence supporting a role for
cholinergic dysfunction in age-related memory disturbances is critically reviewed. An attempt has …

Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change—report of a national institute of mental health work group

T Crook, RT Bartus, SH Ferris, P Whitehouse… - 1986 - Taylor & Francis
Several reviewers have summarized and critically evaluated the growing literature on age-related
changes in human memory (see, eg, Craik, 1977; Flicker et al., 1985; Fozard, 1985; …

Disease duration and the integrity of the nigrostriatal system in Parkinson's disease

…, Y Chu, TG Beach, CH Adler, GM Halliday, RT Bartus - Brain, 2013 - academic.oup.com
The pace of nigrostriatal degeneration, both with regards to striatal denervation and loss of
melanin and tyrosine hydroxylase-positive neurons, is poorly understood especially early in …

On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis

RT Bartus - Experimental neurology, 2000 - Elsevier
Life's Journey If life is indeed a journey, then poetry must be the map that reveals all its
topographic possibilities… while science is the compass that keeps us from getting lost. —RT …

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

WJ Marks, RT Bartus, J Siffert, CS Davis… - The Lancet …, 2010 - thelancet.com
Background In an open-label phase 1 trial, gene delivery of the trophic factor neurturin via
an adeno-associated type-2 vector (AAV2) was well tolerated and seemed to improve motor …

Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open …

…, AJ Stoessl, CW Olanow, RT Bartus - The Lancet …, 2008 - thelancet.com
Background There is an urgent need for therapies that slow or reverse the progression of
Parkinson's disease (PD). Neurotrophic factors can improve the function of degenerating …

The cholinergic hypothesis: a historical overview, current perspective, and future directions.

RT Bartus, RL Dean, MJ Pontecorvo… - Annals of the New York …, 1985 - psycnet.apa.org
The authors discuss the cholinergic hypothesis of geriatric memory dysfunction, which
proposes the following:(1) Significant, functional disturbances in cholinergic activity occur in the …

Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses

…, D Finkelstein, GR Harsh, DN Louis, RT Bartus… - Nature medicine, 1999 - nature.com
The occurrence of multiple tumors in an organ heralds a rapidly fatal course. Although
intravascular administration may deliver oncolytic viruses/vectors to each of these tumors, its …

Short-term memory in the rhesus monkey: disruption from the anti-cholinergic scopolamine

RT Bartus, HR Johnson - Pharmacology Biochemistry and Behavior, 1976 - Elsevier
Two separate experiments were conducted to evaluate the effects of the anti-cholinergic
scopolamine on primate visual discrimination and short-term memory (STM). In the first …

Delivery of neurturin by AAV2 (CERE‐120)‐mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP‐treated monkeys

…, J Stansell III, M Gasmi, RT Bartus - Annals of Neurology …, 2006 - Wiley Online Library
Objective We tested the hypothesis that gene delivery of the trophic factor neurturin could
preserve motor function and protect nigrostriatal circuitry in hemiparkinsonian monkeys. …